Our findings on HGF-mediated recovery, extend the previously published results to mammary epithelial cells and ErbB2 mammary tumor cells, emphasizing the fact that molecular events present in non tumorigenic cells could be retained during tumor growth and become the basis for drug resistance. The gene discussed is ERBB2; the disease is breast cancer.